Expert perspectives on the diagnosis and management of uncontrolled polycythemia vera in a 60-year-old man.
EP. 1: A Case of Uncontrolled Polycythemia Vera
Expert Prithviraj Bose, MD, reviews standard practices in diagnosing and risk stratifying uncontrolled polycythemia vera in the context of a patient case.
EP. 2: An Overview on Polycythemia Vera Management
A comprehensive review of the treatment armamentarium for polycythemia vera, as well as strategies to monitor patients on therapy in this setting.
EP. 3: Uncontrolled PV: Treating Patients With HU Resistance or Intolerance
Considerations for therapy when patients with polycythemia vera experience hydroxyurea resistance or intolerance.
EP. 4: Ruxolitinib in Uncontrolled PV: RESPONSE and RESPONSE-2 Trials
In discussing the role of ruxolitinib in HU-resistant or intolerant PV, expert Prithviraj Bose, MD, highlights data from the RESPONSE and RESPONSE-2 clinical trials.
EP. 5: Long-term Management Strategies for Patients With PV
Expert perspectives on long-term management of patients with polycythemia vera, with regard for the risk of developing secondary MF or AML.
EP. 6: Unmet Needs and Future Directions in Polycythemia Vera Management
Description: Before closing out his discussion on polycythemia vera management, Prithviraj Bose, MD, shares excitement for emerging therapeutics in this setting.
2 Clarke Drive Cranbury, NJ 08512